Immunohistochemical detection of arginase-I expression in formalin-fixed lung and other tissues

Journal of Histotechnology

Volumn 36, Issue 4, 2013, Pages 128-134

  Hochstedler, Christine M ^a   Leidinger, Mariah R ^a   Maher Sturm, Mary T ^a   Gibson Corley, Katherine N ^a   Meyerholz, David K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Arginase; Arginase I; Arginine; Asthma; Cystic fibrosis; Immunohistochemistry; Liver; Lung

Indexed keywords

ARGINASE 1; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INTESTINE; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PANCREAS; PROTEIN EXPRESSION; SALIVARY GLAND; SKIN; STANDARDIZATION;

EID: 84893051066     PISSN: 01478885     EISSN: 20460236     Source Type: Journal    
DOI: 10.1179/2046023613Y.0000000032     Document Type: Article

References (48)

1. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Rhoads JM, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153-68.
2. Marion V, Sankaranarayanan S, de Theije C, van Dijk P, Lindsey P, Lamers MC, et al. Arginine deficiency causes runting in the suckling period by selectively activating the stress kinase GCN2. J Biol Chem. 2011;286:8866-74.
3. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336:1-17.
4. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap? Mol Genet Metab. 2004;81:S38-44.
5. Li H, Meininger CJ, Hawker JR Jr, Haynes TE, Kepka-Lenhart D, Mistry SK, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab. 2001;280:E75-82.
6. Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE, et al. Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr. 2005;135:714-21.
7. Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, et al. Beneficial effect of a longterm oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. AmJ Physiol Endocrinol Metab. 2006;291:E906-12.
8. Wu Z, Satterfield MC, Bazer FW, Wu G. Regulation of brown adipose tissue development and white fat reduction by Larginine. Curr Opin Clin Nutr Metab Care. 2012;15:529-38.
9. Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol. 1997;29:8-15.
10. Wu G, Meininger CJ. Arginine nutrition and cardiovascular function. J Nutr. 2000;130:2626-9.
11. Kuo MT, Savaraj N, Feun LG. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget. 2010;1:246-51.
12. Grasemann H, Schwiertz R, Matthiesen S, Racké K, Ratjen F. Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med. 2005;172:1523-8.
13. Grasemann H, Shehnaz D, Enomoto M, Leadley M, Belik J, Ratjen F. L-Ornithine derived polyamines in cystic fibrosis airways. PLoS One. 2012;7:e46618.
14. Maarsingh H, Zaagsma J, Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol. 2009;158:652-64.
15. Grasemann H, Tullis E, Ratjen F. A randomized controlled trial of inhaled L-Arginine in patients with cystic fibrosis. J Cyst Fibros. 2013;12:468-474.
16. Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, et al. Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood. 2010;115:5214-21.
17. Gibson-Corley KN, Hochstedler C, Sturm M, Rogers J, Olivier AK, Meyerholz DK. Successful integration of the histology core laboratory in translational research. J Histotechnol. 2012;35:17-21.
18. Olivier AK, Naumann P, Goeken A, Hochstedler C, Sturm M, Rodgers JR, et al. Genetically modified species in research: opportunities and challenges for the histology core laboratory. J Histotechnol. 2012;35:63-7.
19. Leung C, Churg A, Wright J, Elliott MW. Effects of isopropanol storage time on histochemical and immunohistochemical stains in lung tissue. J Histotechnol. 2011;34:132-7.
20. Ramos-Vara JA. Technical aspects of immunohistochemistry. Vet Pathol. 2005;42:405-26.
21. Richendrfer HA, Wetzel JA, Swann JM. Temperature, peroxide concentration, and immunohistochemical staining method affects staining intensity, distribution, and background. Appl Immunohistochem Mol Morphol. 2009;17:543-6.
22. Sekine S, Ogawa R, Mcmanus MT, Kanai Y, Hebrok M. Dicer is required for proper liver zonation. J Pathol. 2009;219:365-72.
23. Yu H, Yoo PK, Aguirre CC, Tsoa RW, Kern RM, Grody WW, et al. Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J Histochem Cytochem. 2003;51:1151-60.
24. Akiba T, Kuroiwa N, Shimizu-Yabe A, Iwase K, Hiwasa T, Yokoe H, et al. Expression and regulation of the gene for arginase I in mouse salivary glands: requirement of CCAAT/ enhancer-binding protein alpha for the expression in the parotid gland. J Biochem. 2002;132:621-7.
25. Choi S, Park C, Ahn M, Lee JH, Shin T. Immunohistochemical study of arginase 1 and 2 in various tissues of rats. Acta Histochem. 2012;114:487-94.
26. Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for valid histopathologic scoring in research. Vet Pathol. 2013; Apr 4. doi: 10.1177/0300985813485099. [Epub ahead of print].
27. Treuting PM, Dintzis SM. Salivary glands. In: Treuting PM, Dintzis SM, editors. Comparative anatomy and histology: a mouse and human atlas. San Diego, CA, USA: Academic Press; 2012. p. 111-20.
28. Nelson MP, Christmann BS, Werner JL, Metz AE, Trevor JL, Lowell CA. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol. 2011;186:2372-81.
29. Treuting PM, Clifford CB, Sellers RS, Brayton CF. Of mice and microflora: considerations for genetically engineered mice. Vet Pathol. 2012;49:44-63.
30. Lange PS, Langley B, Lu P, Ratan RR. Novel roles for arginase in cell survival, regeneration, and translation in the central nervous system. J Nutr. 2004;134:2812S-7S.
31. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol. 2001;167:6533-44.
32. Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, et al. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013;26:782-91.
33. Que LG, Kantrow SP, Jenkinson CP, Piantadosi CA, Huang YC. Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol. 1998;275(1 Pt 1):L96-102.
34. Yan BC, Gong C, Song J, Krausz T, Tretiakova M, Hyjek E, et al. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010;34:1147-54.
35. Oglesbee M, Krakowka S. Cellular stress response induces selective intranuclear trafficking and accumulation of morbillivirus major core protein. Lab Invest. 1993;68:109-17.
36. McGee DJ, Kumar S, Viator RJ, Bolland JR, Ruiz J, Spadafora D, et al. Helicobacter pylori thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses. J Biol Chem. 2006;281:3290-6.
37. Endo M, Oyadomari S, Terasaki Y, Takeya M, Suga M, et al. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol. 2003;285(2):L313-21.
38. Kenyon NJ, Bratt JM, Linderholm AL, Last MS, Last JA. Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences. Toxicol Appl Pharmacol. 2008;230:269-75.
39. Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004;64:5839-49.
40. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787-95.
41. Meyerholz DK, Rodgers J, Castilow EM, Varga SM. Alcian Blue and Pyronine Y histochemical stains permit assessment of multiple parameters in pulmonary disease models. Vet Pathol. 2009;46:325-8.
42. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol. 2009;296:L911-20.
43. Ali NK, Jafri A, Sopi RB, Prakash YS, Martin RJ, Zaidi SI. Role of arginase in impairing relaxation of lung parenchyma of hyperoxia-exposed neonatal rats. Neonatology. 2012;101:106-15.
44. Yang M, Rangasamy D, Matthaei KI, Frew AJ, Zimmermann N, Mahalingam S, et al. Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol. 2006;177:5595-603.
45. Meyerholz DK, Stoltz DA, Namati E, Ramachandran S, Pezzulo AA, Smith AR, et al. Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children. Am J Respir Crit Care Med. 2010;182:1251-61.
46. Stoltz DA, Rokhlina T, Ernst SE, Pezzulo AA, Ostedgaard LS, Karp PH, et al. Intestinal CFTR Expression Alleviates Meconium Ileus in Cystic Fibrosis Pigs. J Clin Invest. 2013;123(6):2685-93.
47. Ostedgaard LS, Meyerholz DK, Chen J, Pezzulo AA, Karp PH, Rokhlina T, et al. The DF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci Transl Med. 2011;3:74ra24.
48. Koziol-White CJ, Panettieri RA Jr. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunol Rev. 2011;242:178-85.